MetroHealth
  Medical Staff Directory    MetroHealth Homepage   
 
  Kevin D. Mullen, MD
Director of Hepatology
Director of Gastroenterology Fellowship Program
Professor, Case Western Reserve University School of Medicine
 
Specialty: Gastroenterology
Digestive Disorders
Colon
Certification: American Board of Internal Medicine
American Board of Internal Medicine/Gastroenterology
MetroHealth Appointment: 1986
 
LocationDivisionAppointment
MetroHealth Medical CenterGastroenterology216-778-5736
 
Medical School: University College of Dublin, Ireland
Internship: Mater Hospital, Ireland
Victoria General Hospital, Canada
Residency: McMaster University, Canada
Fellowship: MetroHealth Medical Center, Cleveland, Ohio
National Institutes of Health, Baltimore, Maryland
Research Interests: Cirrhosis
Hepatitis C
Hepatic Encephalopathy
Selected Publications: Mullen KD, Howard R. Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy? Nat Clin Pract Gastroenterol Hepatol 2005;2:264-265.

Ghanta RK, Mullen KD. Placebo controlled treatment trials in hepatic encephalopathy are feasible and ethical. Hepatology 2005;42:1206-1207.

Sanaka MR, Super DM, Mullen KD, Ferguson DR, McCullough AJ. Use of Tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: A prospective, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2006 23:669-74.

Sanaka M, Super D, Mullen KD, Ferguson DR, Feldman E, McCullough AJ. Improving compliance with post-polypectomy surveillance guidelines: An interventional study using a continuous quality improvement initiative. Gastroenterol Endosc. 2006; 63:97-103.

Dasarathy S, Mullen KD, Dodig M, Donofrio B, McCullough A. Inhibition of aromatase improves nutritional status following portacaval anastomosis in male rats. J Hepatol. 2006 45:214-20.

Mullen KD, Ghanta R, Putka B. Prevention of hepatic encephalopathy after TIPS: No easy task! Hepatology 2006 43:1155-6.

 
Back to Search Results